102.67

0.59% 0.60

Pre-mercato: 102.18 -0.49 -0.48%

Guardant Health Inc (GH)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché GH Giù? Forum Previsione

Precedente Chiudi:

$102.07

Aprire:

$104.12

Volume 24 ore:

1.95M

Relative Volume:

0.75

Capitalizzazione di mercato:

$13.33B

Reddito:

$692.26M

Utile/perdita netta:

$-512.41M

Rapporto P/E:

-24.21

EPS:

-4.24

Flusso di cassa netto:

$-274.36M

1 W Prestazione:

-1.44%

1M Prestazione:

+8.80%

6M Prestazione:

+108.30%

1 anno Prestazione:

+195.37%

Intervallo 1D:

$102.20

$105.01

Intervallo di 1 settimana:

$100.21

$106.00

Portata 52W:

$29.91

$112.42

Guardant Health Inc Stock (GH) Company Profile

Nome

Guardant Health Inc

Settore

Healthcare (1131)

Industria

Diagnostics & Research (54)

Telefono

855-698-8887

Indirizzo

3100 HANOVER STREET, PALO ALTO

Dipendente

2,021

Cinguettio

@guardanthealth

Prossima data di guadagno

2024-11-06

Ultimi documenti SEC

GH's Discussions on Twitter

Confronta GH con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
GH Guardant Health Inc	102.67	13.26B	692.26M	-512.41M	-274.36M	-4.24
TMO Thermo Fisher Scientific Inc	575.91	215.01B	43.74B	6.58B	6.11B	17.31
DHR Danaher Corp	228.53	159.87B	24.27B	3.50B	5.02B	4.8589
IDXX Idexx Laboratories Inc	700.55	56.23B	4.17B	1.03B	940.22M	12.61
A Agilent Technologies Inc	140.60	39.54B	6.95B	1.30B	1.15B	4.5714
IQV Iqvia Holdings Inc	223.63	37.85B	15.90B	1.28B	2.21B	7.2842

Guardant Health Inc Stock (GH) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-12-02	Ripresa	Morgan Stanley	Overweight
2025-09-25	Aggiornamento	Wolfe Research	Peer Perform → Outperform
2025-09-22	Ripresa	Wells Fargo	Overweight
2025-04-10	Iniziato	Mizuho	Outperform
2025-01-23	Iniziato	Barclays	Overweight
2024-06-28	Aggiornamento	Guggenheim	Neutral → Buy
2024-06-03	Ripresa	Jefferies	Buy
2024-04-24	Ripresa	Craig Hallum	Buy
2023-12-14	Iniziato	Guggenheim	Neutral
2023-12-13	Iniziato	Wolfe Research	Peer Perform
2023-11-13	Aggiornamento	Raymond James	Mkt Perform → Outperform
2023-09-28	Iniziato	Bernstein	Outperform
2023-09-27	Aggiornamento	Piper Sandler	Neutral → Overweight
2023-07-05	Ripresa	JP Morgan	Overweight
2023-05-26	Aggiornamento	Citigroup	Neutral → Buy
2023-05-05	Iniziato	UBS	Buy
2023-03-09	Downgrade	Citigroup	Buy → Neutral
2023-01-05	Iniziato	Scotiabank	Sector Outperform
2022-11-01	Downgrade	Piper Sandler	Overweight → Neutral
2022-10-19	Iniziato	Craig Hallum	Buy
2022-10-06	Iniziato	Stephens	Overweight
2022-08-25	Iniziato	Credit Suisse	Outperform
2022-06-03	Iniziato	Piper Sandler	Overweight
2022-04-28	Ripresa	BTIG Research	Buy
2022-02-24	Reiterato	Canaccord Genuity	Buy
2022-02-24	Reiterato	Citigroup	Buy
2022-02-24	Reiterato	Cowen	Outperform
2022-02-24	Reiterato	Morgan Stanley	Overweight
2022-02-24	Reiterato	SVB Leerink	Outperform
2022-02-24	Reiterato	Stifel	Buy
2022-02-24	Reiterato	Wells Fargo	Overweight
2021-10-15	Ripresa	Cowen	Outperform
2021-06-15	Iniziato	Raymond James	Mkt Perform
2021-06-03	Iniziato	Goldman	Buy
2021-05-25	Iniziato	Wells Fargo	Overweight
2021-01-11	Iniziato	Stifel	Buy
2020-09-09	Iniziato	Morgan Stanley	Overweight
2020-06-12	Iniziato	BTIG Research	Buy
2020-02-21	Iniziato	Guggenheim	Buy
2020-01-07	Iniziato	Citigroup	Buy
2019-08-07	Reiterato	Canaccord Genuity	Buy
2019-04-16	Iniziato	Canaccord Genuity	Buy
2019-04-10	Aggiornamento	BofA/Merrill	Neutral → Buy
2019-02-28	Reiterato	BofA/Merrill	Neutral
2018-10-29	Iniziato	BofA/Merrill	Neutral
2018-10-29	Iniziato	JP Morgan	Overweight
2018-10-29	Iniziato	William Blair	Outperform

Mostra tutto

Guardant Health Inc Borsa (GH) Ultime notizie

Dec 15, 2025

Guardant Health (GH) Sees Analyst Rating Update from Leerink Par - GuruFocus

Dec 15, 2025

Analyst JP Morgan Raises Price Target for Guardant Health (GH) | - GuruFocus

Dec 15, 2025

Guardant Health (NASDAQ:GH) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says - MarketBeat

Dec 15, 2025

Guardant Health (GH) Receives Raised Price Target from Wells Far - GuruFocus

Dec 15, 2025

Dec 14, 2025

Guardant Health (GH): Reassessing Valuation After a Sharp Share Price Recovery - Yahoo Finance

Dec 14, 2025

Nikko Asset Management Americas Inc. Raises Stake in Guardant Health, Inc. $GH - MarketBeat

Dec 14, 2025

Castleark Management LLC Acquires New Stake in Guardant Health, Inc. $GH - MarketBeat

Dec 14, 2025

Dec 13, 2025

Guardant Health (NASDAQ:GH) Stock Price Expected to Rise, BTIG Research Analyst Says - MarketBeat

Dec 13, 2025

Will Guardant Health Inc stock deliver strong dividend growthTake Profit & Step-by-Step Swing Trade Plans - moha.gov.vn

Dec 13, 2025

Eventide Asset Management LLC Sells 107,775 Shares of Guardant Health, Inc. $GH - MarketBeat

Dec 13, 2025

Dec 12, 2025

GeneDx and Guardant Health named as BTIG’s top picks for 2026 - Investing.com Canada

Dec 12, 2025

GH: Analyst Mark Massaro Raises Price Target for Guardant Health | GH Stock News - GuruFocus

Dec 12, 2025

Osterweis Capital Management Inc. Lowers Stock Position in Guardant Health, Inc. $GH - MarketBeat

Dec 12, 2025

Dec 11, 2025

Darya Chudova Sells 13,664 Shares of Guardant Health (NASDAQ:GH) Stock - MarketBeat

Dec 11, 2025

Guardant Health (NASDAQ:GH) Director Sells $131,250.00 in Stock - MarketBeat

Dec 11, 2025

Guardant Health announces proposed $300 million offering of convertible senior notes due 2033 - MSN

Dec 11, 2025

Guardant Health (GH) Jumps to New Record High on Earnings Blowout, Bullish Outlook - MSN

Dec 11, 2025

Citigroup Raises Price Target for GH to $135, Maintains Buy Rati - GuruFocus

Dec 11, 2025

Guardant Health Forms Collaboration With Trial Library to Increase US Access to Cancer Clinical Trials - marketscreener.com

Dec 11, 2025

HighVista Strategies LLC Has $1.47 Million Stake in Guardant Health, Inc. $GH - MarketBeat

Dec 11, 2025

Guardant Health (Nasdaq: GH) links 1M-patient data to Trial Library's 320-clinic network - Stock Titan

Dec 11, 2025

Have Guardant Health Insiders Been Selling Stock? - simplywall.st

Dec 11, 2025

Guardant Health Insider Sold Shares Worth $10,505,474, According to a Recent SEC Filing - marketscreener.com

Dec 11, 2025

Guardant Health director Talasaz sells $10.5 million in shares By Investing.com - Investing.com South Africa

Dec 11, 2025

Guardant Health director Talasaz sells $10.5 million in shares - Investing.com

Dec 11, 2025

Dec 10, 2025

Insider Sell: Kumud Kalia Sells 2,000 Shares of Guardant Health Inc (GH) - GuruFocus

Dec 10, 2025